Check Unicycive Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$70.5M
EPS (TTM)
-2.3163
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.06
Industry PE ratio
0P/B Ratio
0PEG Ratio
0EBITDA
-30.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
17640000.00%
Track how Unicycive Therapeutics Inc P/E has moved over time to understand its valuation trends.
Unicycive Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 18, 2025
Industry (0.00x)
September 18, 2025
Today (-1.06x)
September 18, 2025
Highest (0.00x)
September 18, 2025
Today’s Price to Earnings Ratio: -1.06x
Compare market cap, revenue, PE, and other key metrics of Unicycive Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $70.5M | NA | -1.06 | 0.00% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Unicycive Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Unicycive Therapeutics Inc investment value today
Current value as on today
₹1,09,279
Returns
₹9,279
(+9.28%)
Returns from Unicycive Therapeutics Inc Stock
₹4,326 (+4.33%)
Dollar Returns*
₹4,953 (+4.95%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Unicycive Therapeutics Inc. Average target price of $62
Get share price movements and forecasts by analysts on Unicycive Therapeutics Inc.
What analysts predicted
93.39%UPSIDE
Target Price
$62
Current Price
$4.1
Analyzed by
11 Analysts
Target
$62.00
Unicycive Therapeutics Inc target price $62, a slight upside of 93.39% compared to current price of $4.1. According to 11 analysts rating.
Investment in Unicycive Therapeutics Inc Shares on INDmoney has grown by 61.76% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:61.76% versus previous 30 day period
Search interest for Unicycive Therapeutics Inc Stock has increased by 216% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:216% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, -271.0K → 568.0K (in $), with an average increase of 147.7% per quarter
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 65.5%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 152.1%
Price Dip
In the last 3 months, UNCY stock has moved down by -39.5%
Profit Down
Netprofit is down for the last 2 quarters, 570.0K → -6.44M (in $), with an average decrease of 1231.1% per quarter
Organisation | Unicycive Therapeutics Inc |
Headquarters | 4300 El Camino Real, Los Altos, CA, United States, 94022 |
CEO | Dr. Shalabh K. Gupta M.D., MPA |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Shalabh K. Gupta M.D., MPA | Founder, Chairman, CEO & President |
Dr. Pramod Gupta Ph.D. | Executive Vice President of Operations |
Mr. Douglas Jermasek M.B.A. | Executive Vice President of Corporate Strategy |
Mr. John W. Townsend CPA | Chief Financial Officer |
Unicycive Therapeutics Inc share price today is $4.1 as on at the close of the market. Unicycive Therapeutics Inc share today touched a day high of $4.14 and a low of $4.
Unicycive Therapeutics Inc share touched a 52 week high of $11 on and a 52 week low of $3.4 on . Unicycive Therapeutics Inc stock price today i.e. is closed at $4.1,which is 62.73% down from its 52 week high and 20.59% up from its 52 week low.
Unicycive Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Unicycive Therapeutics Inc (UNCY) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Unicycive Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Unicycive Therapeutics Inc share’s latest price of $4.1 as on September 19, 2025 at 1:29 am IST, you will get 2.4390 shares of Unicycive Therapeutics Inc. Learn more about
fractional shares .